Preventive screening does not only allow to preemptively intervene on pathologies before they can harm the host; but also to reduce the costs of the intervention itself; boosting the efficiency of the NHS (National Health System) by saving resources for other purposes. To improve technology advancements in this field; user‐friendly yet low‐cost devices are required; and various applications for gas sensors have been tested and proved reliable in past studies. In this work; cell cultures and blood samples have been studied; using nanostructured chemoresistive sensors; to both verify if this technology can reliably detect tumor markers; and if correlations between responses from tumor line metabolites and the screening outcomes on human specimens could be observed. The results showed how sensors responded differently to the emanations from healthy and mutant (for cells) or tumor affected (for blood) samples, and how those results were consistent between them, since the tumoral specimens had higher responses compared to the ones of their healthy counterparts. Even though the patterns in the responses require a bigger population to be defined properly; it appeared that the different macro‐groups between the same kind of samples are distinguishable from some of the sensors chosen in the study; giving promising outcomes for further research.

Nanostructured chemoresistive sensors for oncological screening and tumor markers tracking: Single sensor approach applications on human blood and cell samples

Landini, Nicolò
Primo
;
Anania, Gabriele
Secondo
;
Astolfi, Michele;Fabbri, Barbara;Guidi, Vincenzo;Rispoli, Giorgio;Valt, Matteo;Zonta, Giulia
Penultimo
;
Malagù, Cesare
Ultimo
2020

Abstract

Preventive screening does not only allow to preemptively intervene on pathologies before they can harm the host; but also to reduce the costs of the intervention itself; boosting the efficiency of the NHS (National Health System) by saving resources for other purposes. To improve technology advancements in this field; user‐friendly yet low‐cost devices are required; and various applications for gas sensors have been tested and proved reliable in past studies. In this work; cell cultures and blood samples have been studied; using nanostructured chemoresistive sensors; to both verify if this technology can reliably detect tumor markers; and if correlations between responses from tumor line metabolites and the screening outcomes on human specimens could be observed. The results showed how sensors responded differently to the emanations from healthy and mutant (for cells) or tumor affected (for blood) samples, and how those results were consistent between them, since the tumoral specimens had higher responses compared to the ones of their healthy counterparts. Even though the patterns in the responses require a bigger population to be defined properly; it appeared that the different macro‐groups between the same kind of samples are distinguishable from some of the sensors chosen in the study; giving promising outcomes for further research.
2020
Landini, Nicolò; Anania, Gabriele; Astolfi, Michele; Fabbri, Barbara; Guidi, Vincenzo; Rispoli, Giorgio; Valt, Matteo; Zonta, Giulia; Malagù, Cesare
File in questo prodotto:
File Dimensione Formato  
4.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 2.27 MB
Formato Adobe PDF
2.27 MB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2418576
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact